acetaminophen has been researched along with Infections, Meningococcal in 5 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Due to the strong evidence of increased risk of fever after administration, surveillance of adverse events following immunization (AEFIs) is a priority for 4CMenB." | 1.91 | Adverse events following immunization (AEFIs) with anti-meningococcus type B vaccine (4CMenB): Data of post-marketing active surveillance program. Apulia Region (Italy), 2019-2023. ( Ancona, D; Di Lorenzo, A; Martinelli, A; Moscara, L; Stefanizzi, P; Stella, P; Tafuri, S, 2023) |
| "To assess the risk of significant adverse events in premature infants receiving the novel 4-component group B meningococcal vaccine (4CMenB) with their routine immunisations at 2 months of age." | 1.51 | Safety of meningococcal group B vaccination in hospitalised premature infants. ( Beebeejaun, K; Braccio, S; Clarke, P; Heath, PT; Kadambari, S; Kent, A; Ladhani, S, 2019) |
| " Because of the limited clinical experience with the four-component meningococcal B vaccine (4CMenB), active surveillance for adverse events following immunization (AEFI) was conducted." | 1.48 | Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada. ( Billard, MN; Boulianne, N; De Serres, G; Deceuninck, G; Gagné, H; Gariépy, MC; Gilca, V; Landry, M; Ouakki, M; Rouleau, I; Skowronski, DM; Toth, E, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abitbol, V | 1 |
| Sohn, WY | 1 |
| Horn, M | 1 |
| Safadi, MAP | 1 |
| Stefanizzi, P | 1 |
| Di Lorenzo, A | 1 |
| Martinelli, A | 1 |
| Moscara, L | 1 |
| Stella, P | 1 |
| Ancona, D | 1 |
| Tafuri, S | 1 |
| Kent, A | 1 |
| Beebeejaun, K | 1 |
| Braccio, S | 1 |
| Kadambari, S | 1 |
| Clarke, P | 1 |
| Heath, PT | 1 |
| Ladhani, S | 1 |
| De Serres, G | 1 |
| Billard, MN | 1 |
| Gariépy, MC | 1 |
| Rouleau, I | 1 |
| Toth, E | 1 |
| Landry, M | 1 |
| Boulianne, N | 1 |
| Gagné, H | 1 |
| Gilca, V | 1 |
| Deceuninck, G | 1 |
| Ouakki, M | 1 |
| Skowronski, DM | 1 |
| Findlow, J | 1 |
2 reviews available for acetaminophen and Infections, Meningococcal
| Article | Year |
|---|---|
Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review.
Topics: Acetaminophen; Child; Fever; Humans; Meningococcal Infections; Meningococcal Vaccines; Neisseria men | 2023 |
Vaccines for the prevention of meningococcal capsular group B disease: What have we recently learned?
Topics: Acetaminophen; Adolescent; Antipyretics; Chemoprevention; Child; Child, Preschool; Fever; Humans; Im | 2016 |
3 other studies available for acetaminophen and Infections, Meningococcal
| Article | Year |
|---|---|
Adverse events following immunization (AEFIs) with anti-meningococcus type B vaccine (4CMenB): Data of post-marketing active surveillance program. Apulia Region (Italy), 2019-2023.
Topics: Acetaminophen; Antibodies; Cross-Sectional Studies; Fever; Humans; Immunization; Infant; Italy; Meni | 2023 |
Safety of meningococcal group B vaccination in hospitalised premature infants.
Topics: Acetaminophen; Anti-Bacterial Agents; Body Temperature; C-Reactive Protein; England; Humans; Infant, | 2019 |
Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada.
Topics: Acetaminophen; Adolescent; Child; Child, Preschool; Female; Fever; Humans; Immunization Programs; Im | 2018 |